UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury

Nature communications, 2018-04, Vol.9 (1), p.1344-18, Article 1344

2018

Volltextzugriff (PDF)

PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

Cancer discovery, 2017-08, Vol.7 (8), p.884-899

2017

Volltextzugriff (PDF)

Targets for cancer therapy in childhood sarcomas

Cancer treatment reviews, 2010-06, Vol.36 (4), p.318-327

2010

Volltextzugriff (PDF)

Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma

International journal of cancer, 2012-11, Vol.131 (9), p.2153-2164

2012

Volltextzugriff (PDF)

Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced

Stem cell reports, 2015-08, Vol.5 (2), p.248-263

2015

Volltextzugriff (PDF)

Abstract 4457: Chromatin remodeling as a potential new strategy for fusion positive rhabdomyosarcoma therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4457-4457

2016

Volltextzugriff (PDF)

Abstract 4630: Characterizing oncogene addiction in alveolar rhabdomyosarcoma reveals novel strategies for combination therapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4630-4630

2018

Volltextzugriff (PDF)

Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

The Journal of clinical investigation, 2010-04, Vol.120 (4), p.1310-1323

2010

Volltextzugriff (PDF)

Abstract 700: Characterization of the mode of action of Fenretinide treatment in alveolar rhabdomyosarcoma cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.700-700

2017

Volltextzugriff (PDF)

Abstract 3109: Protein stability screen to identify compounds destabilizing EWS-FLI1 in Ewing sarcoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3109-3109

2019

Volltextzugriff (PDF)

Abstract 2449: Hedgehog pathway inhibition sensitizes embryonal rhabdomyosarcoma to standard chemotherapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2449-2449

2016

Volltextzugriff (PDF)

Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance

Molecular cancer research, 2021-06, Vol.19 (6), p.1051-1062

2021

Volltextzugriff (PDF)

Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma

The Journal of clinical investigation, 2016-11, Vol.126 (11), p.4237-4249

2016

Volltextzugriff (PDF)

Abstract B19: Identification of physiologically relevant EWS-FLI1 target genes in Ewing’s sarcoma via CRISPRa screening

Cancer research (Chicago, Ill.), 2020-07, Vol.80 (14_Supplement), p.B19-B19

2020

Volltextzugriff (PDF)

Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma

Nature communications, 2024-07, Vol.15 (1), p.6307-14, Article 6307

2024

Volltextzugriff (PDF)

Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies

Modern pathology, 2021-04, Vol.34 (4), p.748-757

2021

Volltextzugriff (PDF)

Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines

Leukemia, 2024-06, Vol.38 (6), p.1315-1322

2024

Volltextzugriff (PDF)

Abstract 2151: Characterization of a novel anti-apoptotic signaling pathway downstream of FGFR4 in rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2151-2151

2011

Volltextzugriff (PDF)

Abstract B01: Development of an in vitro drug-profiling platform for functional guidance of treatment decisions and identification of vulnerabilities in chemoresistant relapsed rhabdomyosarcoma tumors

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (19_Supplement), p.B01-B01

2018

Volltextzugriff (PDF)

The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category

Leukemia, 2024-07, Vol.38 (7), p.1617-1620

2024

Volltextzugriff (PDF)

Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization

Neoplasia (New York, N.Y.), 2022-05, Vol.27, p.100784-100784

2022

Volltextzugriff (PDF)

Abstract PR10: The chromatin remodeler CHD4 as a potential specific target for alveolar rhabdomyosarcoma therapy

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (5_Supplement), p.PR10-PR10

2016

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(102)
Humans
(91)
Animals
(44)
Oncology
(37)
Female
(34)
Male
(31)
Mice
(31)
Biological And Medical Sciences
(23)
Biochemistry & Molecular Biology
(22)
Cell Biology
(22)
Rhabdomyosarcoma
(22)
Base Sequence
(21)
Molecular Sequence Data
(20)
Cell Line, Tumor
(17)
Middle Aged
(16)
Tumors
(16)
Multidisciplinary Sciences
(15)
Proteins
(15)
Science & Technology - Other Topics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(18)
Plos One
(10)
Blood
(6)
Frontiers In Oncology
(4)
Nature Communications
(4)
Oncotarget
(4)
The Journal Of Biological Chemistry
(4)
Biochemical And Biophysical Research Communications
(3)
Biochemistry
(3)
Cancers
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury

PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

Targets for cancer therapy in childhood sarcomas

Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma

Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced

Abstract 4457: Chromatin remodeling as a potential new strategy for fusion positive rhabdomyosarcoma therapy

Abstract 4630: Characterizing oncogene addiction in alveolar rhabdomyosarcoma reveals novel strategies for combination therapy

Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance

Abstract 700: Characterization of the mode of action of Fenretinide treatment in alveolar rhabdomyosarcoma cells

Abstract 3109: Protein stability screen to identify compounds destabilizing EWS-FLI1 in Ewing sarcoma

Abstract 2449: Hedgehog pathway inhibition sensitizes embryonal rhabdomyosarcoma to standard chemotherapy

Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance

Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma

Abstract B19: Identification of physiologically relevant EWS-FLI1 target genes in Ewing’s sarcoma via CRISPRa screening

Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies

Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines

Abstract 2151: Characterization of a novel anti-apoptotic signaling pathway downstream of FGFR4 in rhabdomyosarcoma

Abstract B01: Development of an in vitro drug-profiling platform for functional guidance of treatment decisions and identification of vulnerabilities in chemoresistant relapsed rhabdomyosarcoma tumors

The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category

Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization

Abstract PR10: The chromatin remodeler CHD4 as a potential specific target for alveolar rhabdomyosarcoma therapy

Suchergebnisse filtern